Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
S2GΔHR2 I3-01v9 SApNP
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/19/2021
P5A-3C12
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-2F11
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-1B9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-2G7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P2B-1A1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-1B6
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-2G9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-1B8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-3A1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P2B-1A10
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
RBD-Fc Vacc
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/17/2021
Dactolisib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
Berzosertib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
ChAd-SARS-CoV-2-S
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/17/2021
Zofin
Potential treatment - clinical evidence Experimental Other treatment Mar/17/2021
COV2-2489
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/16/2021
COV2-2676
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/16/2021
mAb 4A8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
mAB 4-8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021